Molecular mechanisms of pirfenidone activity in human lung fibroblasts

E. Conte, M. Fruciano, E. Gili, E. Fagone, M. Iemmolo, C. Vancheri (Catania, Italy)

Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Session: Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Session type: Thematic Poster Session
Number: 825
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Conte, M. Fruciano, E. Gili, E. Fagone, M. Iemmolo, C. Vancheri (Catania, Italy). Molecular mechanisms of pirfenidone activity in human lung fibroblasts. Eur Respir J 2014; 44: Suppl. 58, 825

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mitophagic regulation of myofibroblast differentiation in lung fibroblasts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014


Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Proteasome function in lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

The role of Foxc2 gene in lung development
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014


AAV-Tgfb1 vs. bleomycin: Analysis of gene expression profiles in two models of pulmonary fibrosis
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014

Molecular pathway perturbations in pulmonary sarcoidosis
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Increased levels of glycosaminoglycans in lungs from patients with IPF
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Mining common pathway deregulation profiles in lung diseases
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014


Loss of CARM1 prolongs bleomycin-induced pulmonary fibrosis
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP)
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

The role of cyclooxygenas-2 in the protection against apoptosis in vascular endothelial cells induced by cigarette smoking
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Metabolomic profiling of the lung in a murine model of emphysema
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014

Lung under experimental atherosclerosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Lipoxin (LXA4) as a novel therapy for idiopathic pulmonary fibrosis
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014


A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis
Source: International Congress 2014 – Cell biology 2014
Year: 2014


Immunoproteasome expression in pulmonary fibrosis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Surface expression of CTLA-4 on CD4/CD25high cells in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014


Dynamics of cytokines in patients with severe asthma with extracorporeal immune lymphocytes modification
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014